About Accretion Nutraveda Limited
Data last updated: 22 December 2025
Accretion Nutraveda Limited is a public limited company based in Ahmedabad, Gujarat, India, recognised as a startup by DPIIT. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 16 March 2021, the company has been in operation for over 5 years.
Registered with ROC Ahmedabad under CIN U24290GJ2021PLC121216.
Capital: an authorised share capital of ₹8 Cr and a paid-up capital of ₹5.32 Cr. It is led by directors including Hardik Mukundbhai Prajapati and Harshad Nanubhai Rathod.
Last AGM: 11 September 2025. Financial statements filed for year ended 31 March 2025. Office: 27 Xcelon Industrial Park – 1 Vasna – Chacharwadi Ta – Sanand, Ahmedabad, Gujarat, India – 382213.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.01 Cr, reflecting significant growth compared to the previous year.
The company is associated with 1 brand - Accretion Pharmaceuticals. As per MCA filings, the company has open charges of ₹3.46 Cr on record.
For more details, the company can be reached via its website accretionpharma.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered Address27 Xcelon Industrial Park – 1 Vasna – Chacharwadi Ta – Sanand, Ahmedabad, Gujarat, India – 382213
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Accretion Nutraveda Limited
Accretion Nutraveda Limited has one previous CIN (Corporate Identification Number): U24290GJ2021PTC121216. The current CIN is U24290GJ2021PLC121216, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24290GJ2021PLC121216 | Current |
| U24290GJ2021PTC121216 | Previous |
Associated Brands with Accretion Nutraveda Limited
Accretion Nutraveda Limited operates one associated brand: Accretion Pharmaceuticals. These brands represent Accretion Nutraveda Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Tablets, capsules, and oral liquids are manufactured for therapeutic categories. | accretionpharma.com |
Competitors & Alternatives of Accretion Nutraveda Limited
Brands and companies operating in the same space as Accretion Nutraveda Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Jubilant Life Sciences
|
Company offering a suite of R&D and manufacturing services for small molecules and generics | Noida, India, India | 1978 |
Akums
|
CDMO focusing on spectrum of dosage forms and therapeutic segments | Delhi, India, India | 2004 |
Nectar Lifesciences
|
Cephalosporin APIs and generic formulations are manufactured. | Chandigarh, India, India | 1995 |
Windlas
|
Biopharma regulatory affairs, quality control, and strategy services are provided. | Gurugram, India, India | 2001 |
Unither
|
Contract development and manufacturing organization for proprietary and generic drugs | Paris, France, France | 1993 |
Recipharm
|
Pharmaceutical development and manufacturing services are offered contractually. | Jordbro, Sweden, Sweden | 1995 |
CoreRx
|
CDMO with a focus on early phase drug product development | Clearwater, United States, United States | 2006 |
MedPharm
|
Topical and inhaled drug delivery formulations are developed and manufactured. | Guildford, United Kingdom, United Kingdom | 1998 |
Board of Directors of Accretion Nutraveda Limited
Accretion Nutraveda Limited is currently managed by 10 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hardik Mukundbhai Prajapati | Director | 16 Mar 2021 | 5 Years 3 Months | Current |
|
Harshad Nanubhai Rathod
Also directs:
Accretion Pharmaceuticals Limited
|
Director | 16 Mar 2021 | 5 Years 3 Months | Current |
| Mayur Popatlal Sojitra | Managing Director | 16 Mar 2021 | 5 Years 3 Months | Current |
|
Shruti Gupta
Also directs:
Arjun Jewellers Limited, Super Fine Knitters Limited, Checkpoint Trends Limited and 3 more
|
Director | 11 Sep 2025 | 0 Years 10 Months | Current |
|
Mahipal Singh Chouhan
Also directs:
Emmbi Industries Limited, Navigant Corporate Advisors Limited, Weldor Cnc Machines Limited and 1 more
|
Director | 11 Sep 2025 | 0 Years 10 Months | Current |
|
Arun Dash
Also directs:
Weldor Cnc Machines Limited, Arjun Jewellers Limited, Dash Dwivedi & Associates Llp and 1 more
|
Director | 11 Sep 2025 | 0 Years 10 Months | Current |
Financials of Accretion Nutraveda Limited FY 2025 filings available
Accretion Nutraveda Limited reported revenue of ₹16.01 Cr (up 212% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Accretion Nutraveda Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 May 2021 | Indian Bank | ₹3.46 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Accretion Nutraveda Limited
View historical data on people associated with Accretion Nutraveda Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Accretion Nutraveda Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Accretion Nutraveda Limited
GSTIN & GST Filing Data of Accretion Nutraveda Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Accretion Nutraveda Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Accretion Nutraveda Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Accretion Nutraveda Limited
MSME Payment Delays by Accretion Nutraveda Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Accretion Nutraveda Limited
Subsidiaries & Group Companies of Accretion Nutraveda Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Accretion Nutraveda Limited with ownership details.
MCA Filings & Documents of Accretion Nutraveda Limited
MCA Filings & Documents of Accretion Nutraveda Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Accretion Nutraveda Limited
Frequently Asked Questions about Accretion Nutraveda Limited
Accretion Nutraveda Limited is an active public limited company in the pharma sector based in Ahmedabad, Gujarat, India. It was incorporated on 16 March 2021 (5+ years old) and is registered under CIN U24290GJ2021PLC121216.
Accretion Nutraveda Limited reported revenue of ₹16.01 Cr for FY 2025 (up 212.00% YoY).
The current directors of Accretion Nutraveda Limited are:
The primary industry of Accretion Nutraveda Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes, Accretion Nutraveda Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Accretion Nutraveda Limited can be reached at the registered office: 27 Xcelon Industrial Park – 1 Vasna – Chacharwadi Ta – Sanand, Ahmedabad, Gujarat, India – 382213, or through the website accretionpharma.com.